Cargando…

Resolution of Refractory Corneal Neovascularization with Subconjunctival Bevacizumab

Corneal neovascularization (CNV) has a variety of causes and threatens corneal clarity, thus optimal visual acuity. Conventional medical management includes topical steroids and matrix metalloproteinase inhibitors like doxycycline. Anti-vascular endothelial growth factor (anti-VEGF) agents have demo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Britton, Anna Krystyna, Crayford, Basil Bamford
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772892/ https://www.ncbi.nlm.nih.gov/pubmed/33442379 http://dx.doi.org/10.1159/000510114

Ejemplares similares

Regression of Iris Neovascularization after Subconjunctival Injection of Bevacizumab
por: Ryoo, Na Kyung, et al.
Publicado: (2013)

Short-term regression of corneal neovascularization with combination therapy of argon green laser photocoagulation and subconjunctival bevacizumab
por: Anand, Nandita, et al.
Publicado: (2019)

Ranibizumab Injection for Corneal Neovascularization Refractory to Bevacizumab Treatment
por: Ahn, Ye Jin, et al.
Publicado: (2014)

Treatment of corneal neovascularization in ocular chemical injury with an off-label use of subconjunctival bevacizumab: a case report
por: Iannetti, Ludovico, et al.
Publicado: (2013)

The effect of subconjunctival bevacizumab on corneal neovascularization, inflammation and re-epithelization in a rabbit model
por: Mello, Glauco Reggiani, et al.
Publicado: (2011)

Comparison of different doses of subconjunctival sunitinib with bevacizumab in the treatment of corneal neovascularization in experimental rats
por: Hashemian, Mohammad Nasser, et al.
Publicado: (2017)

The efficiency of subconjunctival bevacizumab in refractory glaucoma - case report
por: Popescu, V, et al.
Publicado: (2015)

Successful regression of newly formed corneal neovascularization by subconjunctival injection of bevacizumab in patients with chemical burns
por: Peng, Wen-yan, et al.
Publicado: (2023)

Inhibition of Corneal Neovascularization by Topical and Subconjunctival Tigecycline
por: Goktas, Sertan, et al.
Publicado: (2014)

Subconjunctival bevacizumab and argon laser photocoagulation for preexisting neovascularization following deep lamellar anterior keratoplasty
por: Lakshmipathy, Meena, et al.
Publicado: (2019)

Subconjunctival Bevacizumab as an Adjunct to Trabeculectomy in Eyes with Refractory Glaucoma: A Case Series
por: Choi, Jin Young, et al.
Publicado: (2010)

Topical versus subconjunctival anti-vascular endothelial growth factor therapy (Bevacizumab, Ranibizumab and Aflibercept) for treatment of corneal neovascularization
por: Al-Debasi, Tariq, et al.
Publicado: (2017)

Simultaneous Subconjunctival Triamcinolone and Bevacizumab Injections for Management of Blepharokeratoconjunctivitis in Children
por: Nguyen, Chu Luan, et al.
Publicado: (2018)

The Effect of Bevacizumab on Corneal Neovascularization in Rabbits
por: Kim, Wung-Jae, et al.
Publicado: (2010)

Inhibition of Corneal Neovascularization by Subconjunctival Injection of Fc-Endostatin, a Novel Inhibitor of Angiogenesis
por: Yoshida, Junko, et al.
Publicado: (2015)

Chemical injury treated with autologous limbal epithelial stem cell transplantation and subconjunctival bevacizumab
por: Cavallini, Gian Maria, et al.
Publicado: (2014)

Intravitreal bevacizumab as therapy for refractory neovascular glaucoma secondary to iris metastasis of breast carcinoma
por: Vale, Stephanie, et al.
Publicado: (2018)

Wound Dehiscence and Device Migration after Subconjunctival Bevacizumab Injection with Ahmed Glaucoma Valve Implantation
por: Miraftabi, Arezoo, et al.
Publicado: (2016)

Subconjunctival injection of antagomir-21 alleviates corneal neovascularization in a mouse model of alkali-burned cornea
por: Zhang, Yun, et al.
Publicado: (2016)

Treatment of Corneal Neovascularization Using Anti-VEGF Bevacizumab
por: Krizova, Deli, et al.
Publicado: (2014)

Bevacizumab (Avastin(®)) for the management of anterior chamber neovascularization and neovascular glaucoma
por: Brouzas, Dimitrios, et al.
Publicado: (2009)

Low-dose subconjunctival bevacizumab to augment trabeculectomy for glaucoma
por: Sedghipour, Mohammad-Reza, et al.
Publicado: (2011)

Comment on: Role of subconjunctival bevacizumab in primary pterygium surgery
por: Shivalli, Siddharudha, et al.
Publicado: (2016)

Comparison of the Effects of Subconjunctival Injections of Bevacizumab and Interferon Alpha-2a on Corneal Angiogenesis in a Rat Model
por: Bilgin, Sinan
Publicado: (2018)

Five-year visual results of intravitreal bevacizumab in refractory inflammatory ocular neovascularization
por: Mansour, Ahmad M, et al.
Publicado: (2012)

Intrastromal Injection of Bevacizumab in the Management of Corneal Neovascularization: About 25 Eyes
por: Sarah, Belghmaidi, et al.
Publicado: (2016)

Choroideremia associated with choroidal neovascularization treated with intravitreal bevacizumab
por: Palejwala, Neal V, et al.
Publicado: (2014)

A Rare Complication Causing Another Rare Complication: Corneal Dellen with Infiltration Secondary to Subconjunctival Silicon Oil
por: Mohan, Sujatha, et al.
Publicado: (2023)

Subconjunctival Bevacizumab for Primary Pterygium Excision; a Randomized Clinical Trial
por: Razeghinejad, Mohammad-Reza, et al.
Publicado: (2014)

Intravitreal Bevacizumab for Management of Choroidal Osteoma without Choroidal Neovascularization
por: Najafabadi, Farhad Fazel, et al.
Publicado: (2015)

Triamcinolone Acetonide as an Adjunct to Bevacizumab for Prevention of Corneal Neovascularization in a Rat Model
por: Mehrjardi, Hadi Z., et al.
Publicado: (2014)

The Effect of Bevacizumab versus Ranibizumab in the Treatment of Corneal Neovascularization: A Preliminary Study
por: Kim, Jin-Hyoung, et al.
Publicado: (2013)

Subconjunctival ocular filariasis -Case report-
por: Macarie, Sorin Simion, et al.
Publicado: (2017)

Choroidal osteoma with choroidal neovascular membrane: Successful treatment with intravitreal bevacizumab
por: Pandey, Neeraj, et al.
Publicado: (2010)

Intravitreal Bevacizumab (Avastin) Treatment of Neovascular Glaucoma in Ocular Ischemic Syndrome
por: Lee, Sang Joon, et al.
Publicado: (2009)

Subconjunctival bevacizumab to augment trabeculectomy with mitomycin C in the management of failed glaucoma surgery
por: Saeed, Ahmed M, et al.
Publicado: (2014)

Subconjunctival Bevacizumab Injection in Glaucoma Filtering Surgery: A Case Control Series
por: Wang, Jing, et al.
Publicado: (2013)

Mechanisms Controlling the Effects of Bevacizumab (Avastin) on the Inhibition of Early but Not Late Formed Corneal Neovascularization
por: Chen, Wei-Li, et al.
Publicado: (2014)

Spontaneous subconjunctival abscess in congenital lamellar ichthyosis
por: Bubanale, Shivanand C, et al.
Publicado: (2018)

Echographic Evaluation of a Subconjunctival Cystic Lesion
por: De Bernardo, Maddalena, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4vhtci485bq5gvbjfh84sqnut4